The achievements of the modern specific therapy of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: focus on the stimulator of soluble guanylate cyclase riociguat

The achievements of the modern specific therapy of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: focus on the stimulator of soluble guanylate cyclase riociguat

Currently, treatment of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) is focused on three signaling pathways: the NO pathway, the endothelin pathway, and the prostacyclin pathway. Riociguat is the only representative of stimulators of the soluble gua...

Full description

Bibliographic Details
Main Authors: S. E. Gratsianskaya, Z. S. Valieva, T. V. Martynyuk
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2020-10-01
Series:Терапевтический архив
Subjects:
pulmonary arterial hypertension
chronic thromboembolic pulmonary hypertension
stimulators of the soluble guanylate cyclase
riociguat
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/46859/32012

Similar Items

Similar Items